New search | Conferencedetail
Print view

Novel Therapies for Type 2 Diabetes and Obesity Summit

Evvnt Promotion / evvnt
30.05.2023 - 01.06.2023  Embassy Suites by Hilton Boston at Logan Airport, 207 Porter Street, 02128 Boston, Massachusetts, USA
Time: 09:00 to 15:30
Conference themes
The wave of breakthrough therapies in drug-based management of obesity has triggered a renaissance in metabolic disorders. As GLP-1 receptor agonists establish a new gold standard in weight-loss and first-in-class therapies demonstrate additional benefit in type 2 diabetes, stakeholders are flooding in to redefine the metabolic landscape.
Professional congress organizer (PCO)
Hanson Wade

Speakers: Ashish Nimgaonkar, Founder and Chief Executive, Glyscend Therapeutics, Jacob Jeppesen, Vice President, Novo Nordisk, Jerry Colca, Chief Scientific Officer, Cirius Therapeutics, and more

Enquiries and Registration:
Ms. Jade Faulkner
General Medicine
Congress fees
Industry - Conference + Workshop Day: USD 4297.00, Industry - Conference Only: USD 2999.00, Vendor - Conference + Workshop Day: USD 5297.00, Vendor - Conference Only: USD 3799.00
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

newTreeCenter of ExcellenceÖsterreichisches Rotes KreuzÖsterreichische Gesellschaft für Public HealthAnästhesie in Entwicklungsländern e. V.Hilfswerk AustriaEuropean Public Health Association (EUPHA)AGEM - Arbeitsgemeinschaft Ethnologie und Medizin